Pressure BioSciences, Inc. develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler NEP3229, HUB440, HUB880, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT-MicroCaps, PCT-Micro-Pestle, PULSE Tubes, and BaroFlex 8-well Processing Strips, as well as application specific kits. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life sciences institutions in the United States, Europe, and Asia. Pressure BioSciences, Inc. has a collaboration with NutraFuels, Inc. for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was founded in 1978 and is based in South Easton, Massachusetts.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Phone508-230-1828
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.46 million
Profitability
Miscellaneous
Employees17
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
Pressure Biosciences (OTCMKTS:PBIO) Frequently Asked Questions
What is Pressure Biosciences' stock symbol?
Pressure Biosciences trades on the OTCMKTS under the ticker symbol "PBIO."
How were Pressure Biosciences' earnings last quarter?
Pressure Biosciences Inc (OTCMKTS:PBIO) released its quarterly earnings results on Thursday, August, 15th. The company reported ($2.22) EPS for the quarter. The company had revenue of $0.52 million for the quarter. View Pressure Biosciences' Earnings History.
When is Pressure Biosciences' next earnings date?
Has Pressure Biosciences been receiving favorable news coverage?
News coverage about PBIO stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pressure Biosciences earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Pressure Biosciences.
Who are some of Pressure Biosciences' key competitors?
What other stocks do shareholders of Pressure Biosciences own?
Who are Pressure Biosciences' key executives?
Pressure Biosciences' management team includes the folowing people:
- Mr. Richard T. Schumacher, Founder, Pres, CEO, Treasurer, Clerk, Sec. & Director (Age 69)
- Dr. Alexander V. Lazarev, Chief Science Officer (Age 54)
- Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D., Sr. VP of Engineering (Age 64)
- Mr. Richard P. Thomley, Acting Chief Financial Officer (Age 67)
- Dr. Bradford Addison Young, Sr. VP & Chief Commercial Officer (Age 50)
How do I buy shares of Pressure Biosciences?
Shares of PBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Pressure Biosciences' stock price today?
One share of PBIO stock can currently be purchased for approximately $3.24.
How big of a company is Pressure Biosciences?
Pressure Biosciences has a market capitalization of $6.90 million and generates $2.46 million in revenue each year. The company earns $-9,700,000.00 in net income (profit) each year or ($15.33) on an earnings per share basis. Pressure Biosciences employs 17 workers across the globe.View Additional Information About Pressure Biosciences.
What is Pressure Biosciences' official website?
How can I contact Pressure Biosciences?
Pressure Biosciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The company can be reached via phone at 508-230-1828 or via email at [email protected]
MarketBeat Community Rating for Pressure Biosciences (OTCMKTS PBIO)
MarketBeat's community ratings are surveys of what our community members think about Pressure Biosciences and other stocks. Vote "Outperform" if you believe PBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
